tiprankstipranks
Advertisement
Advertisement

SNYNF Stock Latest News

Regeneron price target raised to $737 from $696 at RBC Capital
The FlyRegeneron price target raised to $737 from $696 at RBC Capital
2d ago
SNY
REGN
Sanofi Publishes 2026 Half-Year Financial Report for Investors
PremiumCompany Announcements
Sanofi Publishes 2026 Half-Year Financial Report for Investors
3d ago
Morning Movers: Baxter surges following beat and raise report
PremiumThe Fly
Morning Movers: Baxter surges following beat and raise report
3d ago
MO
BAX
Sanofi expects FY26 sales to grow by around 10% at CER
PremiumThe Fly
Sanofi expects FY26 sales to grow by around 10% at CER
3d ago
SNY
Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported
PremiumThe Fly
Sanofi reports Q2 business EPS EUR 2.09, up 31.4% reported
3d ago
SNY
Sanofi boosts 2026 outlook after strong Q2 driven by Dupixent and new launches
PremiumCompany AnnouncementsSanofi boosts 2026 outlook after strong Q2 driven by Dupixent and new launches
3d ago
Sanofi’s Sarclisa Real‑World Data: What the Latest Multiple Myeloma Update Means for Investors
Premium
Company Announcements
Sanofi’s Sarclisa Real‑World Data: What the Latest Multiple Myeloma Update Means for Investors
4d ago
SNYNF
Sanofi ends amLitelimab program in atopic dermatitis amid portfolio review
Premium
Company Announcements
Sanofi ends amLitelimab program in atopic dermatitis amid portfolio review
9d ago
Sanofi’s Amlitelimab Trial Completion Sets Up a Key Atopic Dermatitis Catalyst
PremiumCompany Announcements
Sanofi’s Amlitelimab Trial Completion Sets Up a Key Atopic Dermatitis Catalyst
11d ago
SNYNF
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
PremiumThe Fly
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
11d ago
XE
AAL
Sanofi Streamlines Executive Committee Ahead of Next Strategic Chapter
PremiumCompany Announcements
Sanofi Streamlines Executive Committee Ahead of Next Strategic Chapter
11d ago
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
PremiumThe Fly
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
12d ago
AZN
BMY
Sanofi announces Executive Committee to support next strategic chapter
PremiumThe FlySanofi announces Executive Committee to support next strategic chapter
12d ago
SNY
Real-World Asthma Data on Dupixent: What Regeneron and Sanofi Investors Should Know
Premium
Company Announcements
Real-World Asthma Data on Dupixent: What Regeneron and Sanofi Investors Should Know
13d ago
REGN
Ligand price target raised to $345 from $330 at Craig-Hallum
Premium
The Fly
Ligand price target raised to $345 from $330 at Craig-Hallum
13d ago
SNY
LGND
Sanofi’s iGlarLixi Diabetes Trial Nears Readout: What Investors Should Watch
PremiumCompany Announcements
Sanofi’s iGlarLixi Diabetes Trial Nears Readout: What Investors Should Watch
23d ago
SNYNF
Sanofi announces subcutaneous Sarclisa Escena approved in U.S.
PremiumThe Fly
Sanofi announces subcutaneous Sarclisa Escena approved in U.S.
23d ago
SNY
Sanofi price target lowered to $49 from $52 at Morgan Stanley
PremiumThe Fly
Sanofi price target lowered to $49 from $52 at Morgan Stanley
25d ago
SNY
ARS Pharmaceuticals announces CEO succession
PremiumThe Fly
ARS Pharmaceuticals announces CEO succession
26d ago
SNY
SPRY
AI Daily: Amazon’s AWS commits $1B toward new unit
PremiumThe FlyAI Daily: Amazon’s AWS commits $1B toward new unit
1M ago
AZN
BMY
Anthropic takes aim at pharma industry with Claude Science, STAT reports
Premium
The Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
1M ago
AZN
BMY
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
Premium
TipRanks Newswire
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
1M ago
SNY
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >